Altitude Labs, an offshoot of AI-focused techbio Recursion, is teaching scientists to build companies, one founder at a time.
Young biotechs usually get acquired instead of profitably selling their own medicines. A growing number are proving they can, ...
Introducing CPC Biotech - one brand uniting critical fluid management components New brand unites CPC’s Biopharma connector ...
On February 16, Franklin Equity said the biotechnology industry has entered 2026 on a firmer footing following an extended ...
MarketBeat on MSN
Biotech Sector May Flip to Market Leader by Year-End
The biotech sector has been one of the market's laggards for several years now, and 2025 has been no different, at least on ...
The biotechnology market is entering a new growth phase, driven by the convergence of genomic science, artificial intelligence, and precision medicine, as global R&D investment approaches $360 billion ...
If you bought XBI a year ago and held it, you are up roughly 65%. If you bought Direxion Daily S&P Biotech Bull 3X Shares ...
A new year brings a fresh Fierce Biotech Fundraising Tracker designed to record the significant amount of venture capital that flows into biopharma. We’re keeping the same guidelines used for last ...
(NASDAQ:KYMR) is among the best biotech stocks. TheFly reported on April 13 that KYMR announced that the U.S. Food and Drug ...
Biotech stocks are emerging from a four-year slump. The SPDR S&P Biotech exchange-traded fund XBI, a proxy for the sector, is up 25% so far this year through Oct. 31, beating the S&P 500 SPX by 9 ...
Looking to invest in biotech stocks? Learn what they are, explore top options, and find out how to get started in this fast-growing, exciting industry.
According to a Securities and Exchange Commission (SEC) filing dated February 17, 2026, Redmile Group increased its position in Krystal Biotech by 16,317 shares. The estimated transaction value was $3 ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results